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Abstract 
Introduction: Brucellar spondylodiscitis is a frequent and serious complication of brucellosis. The aim of this study is to describe the brucellosis 
patients with spondylodiscitis and the predictive factors related to spondylodiscitis in brucellosis. 
Methodology: Laboratory-confirmed brucellosis patients from a low- to medium-endemic region were enrolled in the study and distributed 
into two groups. Group I consisted of patients with spondylodiscitis and Group II patients had no complications. Both groups were compared 
for predictive factors of spondylodiscitis.  
Results: A total of 219 patients with active brucellosis were included in the study. We determined at least one complication in 91 (41.6%) 
patients. The most frequent complication was spondylodiscitis [n = 59 patients (26.9 %)]. In univariate analysis, age, time from symptom onset 
to diagnosis, presence of low back pain, increased levels of erythrocyte sedimentation rate, and alkaline phosphatases were the most significant 
predictive factors for spondylodiscitis among brucellosis cases. Presence of headache and thrombocytopenia were less frequent in patients with 
spondylodiscitis when compared to patients without complications (p = 0.024, p = 0.006 respectively). In multivariate analysis, old age (odds 
ratio [OR] 1,063; 95% confidence interval [CI] 1.026-1.101; p < 0.001), prolonged time between symptoms onset before diagnosis (OR 1.008; 
95% CI 1.001-1.016; p = 0.031), and presence of low back pain (OR 12.886; 95% CI 3.978-41.739; p < 0.001) were indepedently associated 
with an increased risk of spondylodiscitis.  
Conclusions: Spondylodiscitis is the most frequent complication of systemic brucellosis. Patients with low back pain, older age, and longer 
duration of symptoms should be considered as candidates of potential spondylodiscitis in brucellosis. 
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Introduction 
Brucellosis remains one of the most common 
zoonotic diseases worldwide, although it occurs mainly 
in the Mediterranean area, the Middle East, parts of 
Central and South America, and possibly sub-Saharan 
Africa [1]. In Turkey, brucellosis is an important public 
health problem, and it is still an endemic disease. 
Limited veterinary support services and husbandry 
practices favor the spread of infection [2]. Moreover, in 
recent years there has also been uncontrolled migration 
from surrounding countries such as Syria, Iran, Iraq 
where brucellosis is endemic [2-4]. More than 3.5 
million Syrian refugees immigrated to Turkey in the last 
7 years and this also brought about a huge amount of 
uncontrolled movement and smuggling of animals 
across borders. Uncontrolled animal movements can 
contribute to the spread and persistence of zoonotic 
diseases in a regional context [2-5].  
According to reports of the Turkish Ministry of 
Health, the incidence rate of brucellosis cases was 5.30-
16.73/100 000, annually, between 2006 and 2016 [6]. 
Although brucellosis is an infection with minimal 
mortality, it can lead to several organ-based 
complications, such as osteoarticular involvement, 
endocarditis, neurobrucellosis, epididymoorchitis, and 
liver involvement [7]. Osteoarticular complications 
such as peripheral arthritis, spondylodiscitis, 
sacroiliitis, osteomyelitis, tenosynovitis, and bursitis 
are the most common complications [8]. Among 
osteoarticular complications, spondylodiscitis is a 
frequent and serious complication of brucellosis. 
Antibiotic treatment is mostly successful in early stages 
with no or minor neurological deficits; however, 
diagnosis may be delayed, due to the insidious onset of 
symptoms, development of abscess formation in the 
adjacent tissues, and disabiling neurological deficits [9-
11]. Thus, early diagnosis is important. In this study, the 
aim was to describe the clinical features and laboratory 
findings among brucellosis patients with 
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spondylodiscitis, and to determine predictive factors for 
the development of spondylodiscitis in brucellosis. 
 
Methodology 
This prospective, observational study was 
conducted between January 2007 and December 2016 
in Pamukkale University Hospital in Denizli, Turkey, a 
tertiary-care teaching hospital that provides health care 
service for approximately 1-1.2 million people. During 
the study period, demographic data, medical history 
(including epidemiologic risk factors and transmission 
routes), physical examination, laboratory results, 
complications, and treatment were recorded on 
individual, structured patient forms. The diagnosis of 
brucellosis was made according to clinical features and 
laboratory evidence that include: positive Brucella 
Wright agglutination test with ≥ 1/160 titers, positive 
Brucella Coombs test with a titer of ≥ 1/320, and/or the 
isolation of the Brucella species from blood or other 
body fluids or tissue samples [12].  
The patient's clinical presentation was categorized 
into one of three phases based on the duration of 
patients’s symptoms: acute (0–2 months), subacute (2–
12 months), and chronic (> 12 months) [13].  
In the case brucella symptoms reappearing, a 
relapse was considered by a positive blood culture test 
or by increased titers of previous serological tests after 
cessation of the treatment.  
In the case of infection symptoms or physical signs 
at a particular anatomic site, complications were 
diagnosed by performing the following: radiologic 
examinations, such as plain X-ray, ultrasound (USG), 
computerized tomography (CT), magnetic resonance 
imaging (MRI), echocardiography, and microbiological 
tests such as isolation of Brucella spp. from body fluids. 
Diagnosis of spondylodiscitis was made according to 
the clinical findings and characteristic changes on MRI 
or CT scans [14]. 
The patients were grouped into Group I if they had 
spondylodiscitis and Group II if they had no 
complications. In order to determine the predictive 
factors for spondylodiscitis among brucellosis cases, 
we compared factors such as age, time from symptom 
onset to diagnosis, number of relapses, accompanying 
diseases, clinical symptoms, and physical and 
laboratory findings between groups.  
Statistical analysis was performed by SPSS for 
Windows 23.0 (SPSS, Chicago, IL, USA). Mean and 
standard deviations are given in cases of normal 
distribution; otherwise, the data was presented as 
median (range). Student t-test was used for parametric 
data; the Mann-Whitney U-test was used for 
nonparametric data for group comparisons; and Pearson 
chi-square or Fisher exact tests were used for 
categorical data analysis. Differences were considered 
statistically signiﬁcant when the p value was < 0.05. 
Backward stepwise multiple logistic regression was 
performed to identify the independent predictive factors 
associated with an increased risk of spondylodiscitis. 
 
Results 
A total of 219 patients with active brucellosis were 
included in the study, and their annual distribution 
during the study period is shown in Figure 1. There was 
a remarkable number of brucellosis cases between 2007 
and 2009. During the following years between 2010 and 
2016 there was a stable trend of cases. Of the patients, 
113 (51.6%) were male; the mean age was 48.5 ±15.9 
(range: 16–78) years. Of the cases, 110 (50.2%) were 
dealing with livestock, and 36 (30.3%) of them had an 
abortus history of their animals. 137 (62.6%) patients 
had a history of consuming raw or unpasteurized milk 
and other dairy products, and 3 (1.4%) had laboratory 
contact. In 25 patients (11.4%), brucellosis was recently 
reported in family members. In 158 (72.1%) cases, the 
disease course was acute; in 47 (21.5%) cases, 
subacute; and in 14 (6.4%), chronic. Twenty four (11%) 
of the patients were considered to have relapsed. The 
most common presenting symptoms were weakness 
(73.1%), low back pain (58.9%), fever (68.4%), and 
night sweating (57.1%) (Table 1). Of the 120 patients 
from whom blood samples for culture were obtained at 
admission, Brucella spp. was isolated from the blood 
cultures in 59 (49.2%) patients. Typing was possible for 
only 17 isolates, yielding 14 for Brucella melitensis and 
3 for Brucella suis. 
Of the 219 patients, 91 (41.6%) had complications, 
while 128 patients were without complications. The 
most frequent complication was spondylodiscitis, 
which was present in 59 (26.9%) patients (Table 1). 
Lumbar involvement was seen in 41/59 (69.5%) 
Figure 1. Annual distribution of brucellosis from 2007 to 2016. 
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patients; the L3-L4 segment was the most frequently 
involved level, with a rate of 15/59 (25.4%) patients. 
More than one level was affected in 15/59 (25.4%) 
patients. In 25 (42.4%) spondylodiscitis patients, 
abscess was present, and paravertebral involvement 
was the most frequent site (28.8%) (Table 2). Slight 
paraparesis developed in only one patient. Forty-one 
(69.5%) patients with spondylodiscitis were treated 
with triple combination therapy, and the others received 
dual combination therapy. In triple combinations, 25 
(42.4%) patients received rifampicin, doxycycline, and 
trimethoprim sulfamethoxazole, while 16 (27.1%) 
received rifampicin, doxycycline, and aminoglycoside 
(streptomycin or gentamicin). In dual combinations, 17 
(28.8%) patients received rifampicin plus doxycycline, 
the remaining one (1.7%) patient received doxycycline 
plus streptomycin. Median duration of antibiotic 
therapy was 6 (range: 4-9) months. In seven patients, 
abscess drainage was necessary; in another, total 
laminectomy and posterior instrumentation were 
required. 
Old age, prolonged time between symptom onset 
and diagnosis, presence of low back pain, increased 
erythrocyte sedimentation rate (ESR), and alkaline 
phosphatase (ALP) were significant predictive factors 
of spondylodiscitis among brucellosis cases in 
univariate analysis (p < 0.05). Presence of headache and 
thrombocytopenia were less frequent in patients with 
spondylodiscitis when compared to patients without 
complications (p = 0.024 and p = 0.006, respectively) 
(Table 3).  
In multivariate analysis, old age (odds ratio [OR] 
1.063; 95% confidence interval [CI] 1.026-1.101; p < 
0.001), prolonged time between symptom onset and 
diagnosis (OR 1.008; 95% CI 1.001-1.016; p = 0.031), 
and presence of low back pain (OR 12.886; 95% CI 
3.978-41.739; p < 0.001) were indepedently associated 
with an increased risk of spondylodiscitis (Table 4). 
 
Discussion 
Brucellosis remains a public health problem 
worldwide, as well as in Turkey. The incidence of the 
disease is variable in different regions of the country. 
Denizli, where the study was conducted, is a low- to 
medium-endemic area; during the first three years 
(2007-2009) of the study, patient enrollment was 
higher. This difference of enrollment between the first 
three years and the following seven years parallels the 
annual incidence rates reported by the Turkish Ministry 
of Health for Brucella cases [6,15].  
  
Table 1. Symptoms, signs, laboratory findings and 
complications of patients with brucellosis. 
Features Patients, n (%) 
Symptoms  
Fever 129 (58.9) 
Chills 104 (47.5) 
Night sweating 125 (57.1) 
Weakness 160 (73.1) 
Anorexia 86 (39.3) 
Arthralgia 108 (49.3) 
Low back pain 129 (58.9) 
Upper back pain 38 (17.4) 
Headache 49 (22.4) 
Hip pain 46 (21) 
Abdominal pain 26 (11.9) 
Weight loss 38 (17.4) 
Nausea / vomiting 28 (12.8) 
Scrotal pain, swelling * 6 (5.3) 
Physical findings  
Body temperature ≥ 37.5°C 89 (40.6) 
Hepatomegaly 16 (7.3) 
Splenomegaly 15 (6.8) 
Lymphadenopathy 4 (1.8) 
Epididymo-orchitis * 6 (5.3) 
Rash 3 (1.4) 
Laboratory findings  
Leukopenia (Leukocyte 
count < 4000/mm3) 
11 (5) 
Leukocytosis (Leukocyte 
count > 11000/mm3) 
11 (5) 
Anemia (female ≤ 12 g/dL 
and male ≤ 13.5 g/dL) 
118 (53.9) 
Thrombocytopenia (Platelet 
< 150 000/mm3) 
18 (8.2) 
Thrombocytosis (Platelet > 
450 000/mm3) 
15 (6.8) 
Elevated alanine 
transaminase > 40 U/L 
47 (21.5) 
Blood culture positivity, 120 
patients 
59 (49.2) 
Complications  
Spondylodiscitis 59 (26.9) 
Peripheral arthritis 11 (5) 
Knee 8 
Hip 2 
Elbow 1 
Sacroiliitis 9 (4.1) 
Neurobrucellosis 12 (5.5) 
Urogenital system 8 (7.1) 
Epididymo-orchitis 6 
Prostatitis 2 
Cutaneous 3 (1.4) 
Bursitis 2 (0.9) 
Endocarditis 1 (0.5) 
Lung involvement 1 (0.5) 
*: Percentage calculated based on number of male patients. 
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In our study, Brucella spp. was isolated in nearly 
half of the blood cultures, although species typing was 
possible for only 17 isolates (yielding 14 for Brucella 
melitensis and 3 for Brucella suis). Since pig farming is 
not common in Turkey, no cases of B. suis were seen 
until the first human infection that we recently reported 
[16]. The patient who had neurobrucellosis is also one 
of the cases of this study. Of the remaining two cases, 
one had spondylodiscitis (T10-11 segment 
involvement), and the other one had no complications. 
As mentioned above (see Introduction), brucellosis 
can cause significant complications [7]. In the present 
study, of the 219 patients with brucellosis, 
complications were present in 91 (41.6%) patients; the 
most frequent complication was spondylodiscitis, 
present in 59 (26.9%) patients. In previous reports, the 
spondylodiscitis rate in brucellosis was 11.9-39% [17-
20]. Aktug-Demir N et al. [21] reported a 
spondylodiscitis rate of 23.7%, which is similar to our 
data. However, different from our results, in another 
study from Turkey reported a very low spondylodiscitis 
rate as 5.6% [22].  
Distribution of osteoarticular involvements can be 
very diverse, and some studies reported sacroiliitis as 
the most common complication [23-25], whereas others 
reported spondylodiscitis as the most common [18,26]. 
In our study, we found that the frequency of sacroiliitis 
was very low (4.1%). The differences in distribution of 
osteoarticular complications among studies may be due 
to age differences among study groups. Sacroiliitis is 
frequent in younger patients, while spondylodiscitis is 
more common in older patients, such as those in our 
study group [27]. In addition, our hospital is a regional 
reference center that serves more complicated patients, 
and this may be another possible reason for the high 
prevalence of spondylodiscitis.  
In brucellosis, the spinal column can be affected at 
any level, whereas lumbar spine is the most common 
site, particularly the L4-L5 segment [28]. Our results 
showed that lumbar involvement was the most frequent 
site (69.5%) for spondylodiscitis, and one-quarter of 
spondylodiscitis cases involved the L3-L4 segment. In 
previous studies, lumbar involvement was reported as 
60-78% in patients with brucellar spondylodiscitis 
[20,29,30]. One of these studies, the most common site 
was the L4–L5 segment; the level was not specified in 
the two other studies.  
In our series, abscess formation in and around the 
infected area was also frequent (42.4%); the 
paravertebral site was especially common (28.8% of 
cases with spondylodiscitis). Similarly, a recent study 
reported an abscess formation rate of 39.5% and 
paravertebral involvement rate of 21.4% [31]. In 
another study, abscess formation and paravertebral 
involvement were very high, at rates of 81% and 58.3%, 
respectively [29]. Kouba M et al. [20] found an even 
higher rate of paravertebral abscess at 65.6% of 
brucellar spondylodiscitis cases. Kaptan F et al. [19] 
reported that abscess was found in 61.3% of patients 
with brucellar spondylodiscitis and emphasized the 
higher sensitivity of MRI to detect abscess. 
Although some studies revealed that sex might be 
important in spondylodiscitis, our results showed that it 
was not a significant factor [19,21]. 
  
Table 2. Characteristics of spondylodiscitis among 59 patients. 
Vertebral involvement Patients, n (%) 
Lumbar 27 (45.8) 
Thoracic 12 (20.3) 
Thoracolumbar 9 (15.2) 
Cervical 5 (8.5) 
Sacral 1 (1.7) 
Lumbosacral 5 (8.5) 
Localization of abscess 25 (42.4) 
Paravertebral 14 (23.7) 
Epidural 7 (11.9) 
Psoas 1 (1.7) 
Epidural + paravertebral 2 (3.4) 
Paravertebral + psoas 1 (1.7) 
Multiple (> 2 vertebrae) involvement 15 (25.4) 
Procedure 7 (11.9) 
Abscess drainage 5 (8.5) 
Abscess drainage and laminectomy 1 (1.7) 
Abscess drainage and posterior instrumentation 1 (1.7) 
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  Table 3. Univariate analysis for the predictive factors of spondylodiscitis among brucellosis cases. 
Variable 
Group 1 
Spondylodiscitis 
N = 59 (%) 
Group II 
No complications 
N = 128 (%) 
P value 
Age, year, median (IQR) 57 (48-70) 45 (32.25-56) < 0.001 
Male sex, n = 92 (%) 26 (44.1) 66 (51.6) 0.341 
Median (IQR) time symptoms onset to diagnosis, day 45 (30-90) 30 (15-47.5) < 0.001 
Relapse, n = 24 (%) 8 (13.6) 13 (10.2) 0.493 
Accompanying diseases    
Diabetes mellitus 7 (11.9) 9 (7.1) 0.279 
Renal insufficiency 2 (1.6) 0 1 
Connective tissue diseases 1 (1.7) 5 (4) 0.411 
Coroner artery diseases 2 (3.4) 4 (3.1) 1 
COLD 3 (5.2) 4 (3.1) 0.680 
Symptoms    
Fever 32 (54.2) 73 (57.0) 0.720 
Chills 28 (47.5) 59 (46.1) 0.862 
Weakness 45 (76.3) 92 (71.9) 0.528 
Arthralgia 35 (59.3) 58 (45.3) 0.075 
Night sweating 35 (59.3) 73 (57) 0.768 
Anorexia 28 (47.5) 42 (32.8) 0.054 
Low back pain 52 (88.1) 59 (46.1) < 0.001 
Upper back pain 15 (25.4) 19 (15.2) 0.095 
Headache 6 (10.2) 31 (24.4) 0.024 
Hip pain 12 (20.3) 25 (19.5) 0.897 
Abdominal pain 7 (11.9) 14 (10.9) 0.852 
Nausea / vomiting 7 (11.9) 14 (10.9) 0.852 
Weight loss 9 (15.3) 20 (15.9) 0.914 
Physical examination    
Body temperature ≥ 37.5°C 20 (33.9) 49 (38.3) 0.564 
Lymphadenopathy 0 (0) 4 (3.1) 0.310 
Hepatomegaly 5 (8.5) 6 (4.7) 0.313 
Splenomegaly 2 (3.4) 10 (7.8) 0.345 
Laboratory findings    
Leukopenia (leukocyte count < 4000/mm3) 1 (1.7) 9 (7) 0.174 
Leukocytosis (leukocyte count > 11000/mm3) 4 (6.8) 5 (3.9) 0.567 
Anemia (female ≤ 12 g/dL and male ≤ 13.5 g/dL) 32 (54.2) 69 (53.9) 0.966 
Thrombocytopenia (platelet < 150 000/mm3) 0 (0) 14 (10.9) 0.006 
Thrombocytosis (platelet > 450 000/mm3) 6 (10.2) 8 (6.3) 0.344 
Elevated alanine transaminase > 40 U/L 10 (16.9) 31 (24.2) 0.264 
Blood culture positivity, 93 patients 13 (40.6) 34 (55.7) 0.166 
C-reactive protein, mg/dL 3.88 (4.07) 3.18 (4.51) 0.307 
Sedimentation, median (IQR) 46 (27-79) 29 (16-50) < 0.001 
Alkaline phosphatases, IU/L, median (IQR) 110 (84-140) 91 (68.25-116) 0.003 
Therapy duration, months, mean (SD) 6 (4-9) 1.5 (1.5-2) < 0.001 
IQR: Interquartile Range. 
 
 
 
 
 
Table 4. Multivariate analysis for the predictive factors of spondylodiscitis among brucellosis cases. 
Predictive factors OR 95% CI P value 
Age, year, median (IQR) 1.064 1.028-1.102 < 0.001 
Median (IQR) time symptoms onset to diagnosis, day 1.008 1.001-1.016 0.031 
Low back pain 12.886 3.978-41.739 < 0.001 
IQR: Interquartile Range; OR: Odd Ratio; CI: Confidence Interval. 
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The presence of low back pain, older age, and 
prolonged time between symptom onset and diagnosis 
were significant independent predictive factors for 
spondylodiscitis development in our series. Our results 
revealed that there is an approximately 13-fold 
increased risk of spondylodiscitis in brucellosis cases 
with low back pain. Similarly, previous studies showed 
that ‘back or neck pain’ was the most frequent symptom 
[20,32]. 
Older age is another important predictive factor of 
spondylodiscitis in brucellosis patients, and our results 
revealed that patients with spondylodiscitis were more 
likely to be older, with median age as 57 [13,32]. 
Similarly, previous studies reported that [21,33] 
spondylodiscitis was most frequent in older patients.  
The prolonged time between the onset of symptoms 
and the appearance of radiological changes may prevent 
early diagnosis, thus increasing the risk for 
spondylodiscitis [20]. In our study, even a minor delay 
(45 days vs. 30 days) in diagnosis was an important 
predictive factor of spondylodiscitis in brucellosis 
patients. Although previous studies reported longer 
delays in diagnosis, even minor delays can be 
significant in the development of complications 
[13,20,28,32]. Therefore, in older patients and in 
patients who have back pain, earlier diagnosis and 
treatment of brucellosis may prevent complications like 
spondylodiscitis. 
Our results showed that ESR and ALP were 
significant predictive factors of spondylodiscitis among 
brucellosis cases in the univariate analysis, which may 
be related to bone infection. Additionally, our 
multivariate analysis did not prove that these 
parameters are independent predictive factors. Aktug-
Demir N et al. [21] reported that ESR was 
independently associated with brucellar 
spondylodiscitis. Bosilkovski et al. [33] showed that 
significantly-higher ESR was associated with 
osteoarticular brucellosis in univariate analysis. 
Another study found that a total of 78.6% of patients 
with infective spondylodiscitis had elevated ESR, and 
55.6% had elevated levels of ALP [11].  
Headache and thrombocytopenia were more 
frequent in patients without complications in the 
univariate analysis (p = 0.024, p = 0.006, respectively). 
As acute symptoms and discovery of infection, frequent 
complaint of headache and thrombocytopenia can be 
expected in patients without complications.  
The optimal duration of spondylodiscitis treatment 
is not clear; however at least 3-6 months of treatment is 
recommended [13,20]. Mean treatment duration was six 
months among our patients. In 25 (42.4%) patients 
whose spondylodiscitis was complicated with either 
epidural, paravertebral, or psoas abscess, surgical 
drainage was performed as necessary.  
We could not perform blood sampling and Brucella 
species typing with all of our patients, which is a 
limitation of this study. As a result, we could not 
determine the relationship between Brucella species 
and spondylodiscitis development. 
 
Conclusion 
Even though the incidence of brucellosis is 
decreasing with time, serious complications that impact 
treatment and morbidity are still challenging. 
Spondylodiscitis is the most frequent complication of 
systemic brucellosis, especially in older patients. In 
patients with a significant delay between symptom 
onset and diagnosis, the presence of complications 
should be kept in mind at the time of diagnosis. Low 
back pain and older age are the most significant 
predictive factors of spondylodiscitis. Earlier 
consideration of spondylodiscitis in this patient 
population may prevent treatment delays and 
morbidity. 
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